___

1. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher- Rossler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkotter J, McGuire P, Yung A. The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review. JAMA Psychiatry 2013; 70:107-120.

2. Ongur D, Haddad S, Prescot AP, Jensen JE, Siburian R, Cohen BM, Renshaw PF, Smoller JW. Relationship between Genetic Variation in the Glutaminase Gene Gls1 and Brain Glutamine/Glutamate Ratio Measured in Vivo. Biol Pychiatry 2011; 15;70:169-174.

3. Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, Hammond R, Brooks WM, Lauriello J. (1)H-Mrs at 4 Tesla in Minimally Treated Early Schizophrenia. Mol Psychiatry 2010; 15:629-636.

4. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al-Semaan Y, Williamson PC. Glutamate and Glutamine Measured with 4.0 T Proton Mrs in Never-Treated Patients with Schizophrenia and Healthy Volunteers. Am J Psychiatry 2002; 159:1944-1946.

5. Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1h-Mrs Studies. Schizophr Bull 2013; 39:120-129.

6. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic Basis of Brain Activity: Implications for Neuroimaging. Trends Neurosci 2004; 27:489-495.

7. Du F, Cooper A, Lukas SE, Cohen BM, Ongur D. Creatine Kinase and Atp Synthase Reaction Rates in Human Frontal Lobe Measured by (31)P Magnetization Transfer Spectroscopy at 4T. Magn Reson Imaging 2013; 31:102-108.

8. Du F, Zhu XH, Qiao H, Zhang X, Chen W. Efficient in Vivo 31p Magnetization Transfer Approach for Noninvasively Determining Multiple Kinetic Parameters and Metabolic Fluxes of Atp Metabolism in the Human Brain. Magn Reson Med 2007; 57:103-114.

9. Gaisler-Salomon I, Miller GM, Chuhma N, Lee S, Zhang H, Ghoddoussi F, Lewandowski N, Fairhurst S, Wang Y, Conjard- Duplany A, Masson J, Balsam P, Hen R, Arancio O, Galloway MP, Moore HM, Small SA, Rayport S. Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro- Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia. Neuropsychopharmacology 2009: 34;2305-2322.

10. Ongur D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF. Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania. Biol Psychiatry 2008: 15;64:718-726.

11. Kemp GJ. Non-Invasive Methods for Studying Brain Energy Metabolism: What They Show and What It Means. Dev Neurosci 2000: 22;418-428.

12. Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC. Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in Schizophrenia. Biol Psychiatry 2010; 68:625-633.

13. Bustillo JR, Chen H, Gasparovic C, Mullins P, Caprihan A, Qualls C, Apfeldorf W, Lauriello J, Posse S. Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla. Biol Psychiatry 2011: 69:19-27.

14. Aoyama N, Theberge J, Drost DJ, Manchanda R, Northcott 16. Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, S, Neufeld RW, Menon RS, Rajakumar N, Pavlosky WF, Schnepf B, Boeker H, Boesiger P, Northoff G. The Relationship Densmore M, Schaefer B, Williamson PC. Grey Matter and between Aberrant Neuronal Activation in the Pregenual Anterior Social Functioning Correlates of Glutamatergic Metabolite Loss Cingulate, Altered Glutamatergic Metabolism, and Anhedonia in in Schizophrenia. Br J Psychiatry 2011; 198:448-456. Major Depression. Arch Gen Psychiatry 2009; 66:478-486.

15. Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL,

17. Ongur D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Prescot AP, Cohen BM, Pope HG, Renshaw PF, Ongur D. Creatine Abnormalities in Schizophrenia and Bipolar Disorder. Rapid Enhancement of Glutamatergic Neurotransmission Psychiatry Res 2009; 172:44-48. in Bipolar Depression Following Treatment with Riluzole. Neuropsychopharmacology 2010; 35:834-846.